Phalanx is designed to combat early-stage Parkinson’s Disease and reduce the risk of developing new-onset All-Cause Dementia, Alzheimer’s Disease and Parkinson’s Disease using high-intensity exercise and its substantial disease modifying effects.
Early-Stage Parkinson's Disease
The percentage of studies ≥ 6 months long that found early-stage PD patients improved or stabilized on average over the timeframe studied based on the primary disease rating scale used in PD clinical trials (MDS-UPDRS III) following an aerobic-exercise intervention of sufficient volume and intensity.
Click on this box to see more detail on some of the most compelling studies.
Risk Reduction of All-Cause Dementia, Alzheimer's and Parkinson's Disease
The reduction in all-cause dementia observed in UK Biobank participants who engaged in ≥ 140 minutes of moderate-to-vigorous exercise.
Click on this box to see more detail on some of the most compelling studies.
The Program
Deploys via iOS
Deploys a high intensity exercise program to patients via an iOS app.
Increases Exercise Capacity
Designs the exercise program using evidence-based training principles to optimally increase a patient's capacity for high-intensity exercise over time, and therein increase patient access to exercise's disease modifying effect.
Tracks Heart Rate and Program Adherence
Tracks heart rate and program adherence in the iOS app via a wearable device to assess whether the patient is actually reaching the required training volume and heart rate (≥ 85% of Max HR) believed to have the greatest disease modifying effect. Shareable with physician if the patient wishes.
Guides & Supports the Patient
Provides patient guidance and support as needed to help patient's meet program targets, including advising the patient on when and how to increase exercise volume when the patient is able and ready.
Customizes Itself to the Patient
Tailors the weekly program to the patient's current fitness capabilities, preferred exercise modalities, and schedule.
Phalanx’s full exercise program is, and always will be, free.